Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Algorithm for Warfarin Dose Predictor: Protocol for Improvement and Effectiveness of Therapy Anticoagulant

NCT06789588 is registered in ClinicalTrials.gov with University of Pernambuco as lead sponsor.

NCT NCT06789588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06789588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Algorithm for Warfarin Dose Predictor: Protocol for Improvement and Effectiveness of Therapy Anticoagulant
Lead sponsor
University of Pernambuco
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
October 21, 2024
Completion date
July 31, 2027
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)